Erectile dysfunction
- Авторлар: Chalyi M.E1, Akhvlediani N.D1, Kharchilava R.R1
-
Мекемелер:
- Шығарылым: № 2S (2017): Supplement
- Беттер: 20-29
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/289918
- ID: 289918
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Толық мәтін
Әдебиет тізімі
- Аляев Ю.Г., Григорян В.А., Чалый М.Е. Нарушения половой и репродуктивной функции у мужчин. М.: Литтерра, 2006. С. 52-96.
- Глыбочко П.В., Аляев Ю.Г. и соавт. Урология: учебник / под ред. 3-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2013. С. 543-558.
- Глыбочко П.В., Аляев Ю.Г., Чалый М.Е., Ахвледиани Н.Д. Половые расстройства у мужчин. М.: ГЭОТАР-Медиа 2012. С. 15-65.
- Лоран О.Б., Сегал А.С., Щеплев П.А. Простагландин Е1 в диагностике и терапии нарушений эрекции. Урол. и нефрол. 1995;4: 35-38.
- Мазо Е.Б., Гамидов С.И. Эректильная дисфункция. М.: Вече, 2004. 120 с.
- Пушкарь Д.Ю., Верткин А.Л. Эректильная дисфункция: кардиологические аспекты. М.: МЕДпресс-информ, 2005.
- Пушкарь Д.Ю., Сегал А. С., Багаев А.Г., Носовицкий П.Б. Иохимбин в терапии эректильной дисфункции. Урология. 2002;6:34-37.
- Коган М.И. Эректильная дисфункция (текущее мнение). Ростов-на-Дону, 2005. 336 с.
- Кротовский Г.С. Лечение сосудистой импотенции. М., 1998. 159 с.
- Benet A.E., Melman A. The epidemiology of erectile dysfunction. Impotence. Urol. Clin.N. Amer. 1995; 22:699-709.
- Carey M.P., Johnson B.T. Effectiveness of yohimbine in the treatment of erectile disorder: four metaanalytic integrations. Arch.Sex. Behav. 1996;25:341-360.
- DeBusk R., Drory Y., Goldstein I. et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendation of the Princeton consensuspanel. Amer.J. Cardiol. 2000;86:175- 181.
- Feldman H.A., Goldstein I., Hatzichristou D. G. et al. Impotence and itsmedical and psychosocial correlates: Results of the Massachusetts Male AgingStudy. J. Urol. 1994;151:54-61.
- Feldman H.A., Johannes C.D., Derby C.A. et al. Erectile dysfunction and coronary risk factors: Prospective results of the Massachusetts Male Aging Study. Prev. Med. 2000;30:328-338.
- Goldstein J. Lue T.F. Padma-Nathan H. et al. Oral Sildenafil in the treatment of erectile dysfunction // NEJM. 1998;338:1397-1404.
- Hatzichristou D.G., Hatzimouratidis K., Ioannides E. et al. Nocturnal peniletumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J. Urol. 1998;159:1921-1926.
- Kunelius P., Hakkinen J., Lukkarinen O. Is high dose yohimbinehydrochloiide effective in the treatment of mixed-type impotence? A prospective randomized controlled double-blind cross-over study. Urology. 1997;49: 441- 444.
- Levine L.A., Dimitriou R.J. Vacuum-constriction and external erection devices in erectile dysfunction // Urol. Clin. N. Amer.2001;28:335-341.
- Lue T.F. Impotence: a patients goal-directed approach to treatment. World J. Urol. 1990;8:67-74.
- Martinez R., Puigvert A., Pomerol J.M., Rodriguez-Villalba R. Clinical experience with apomorphine hydro-chloride: the first 107 patients. J. Urol. 2003;170:2352-2355.
- Meuleman E.J., Diemont W.L. Investigation of erectile dysfunction. Diagnostics testing for vascular factors in erectile dysfunction. Urol. Clin.N. Amer. 1995;22:803-819.
- Montorsi F., Briganti A., Salonia A. et al. Erectile dysfunction prevalence, time of onset and association with raisk factors in 300 consecutive patients withacute chest pain and angiographically documented coronary artery disease. Eur. Urol. 2003;44:35-38.
- Montorsi F., Padma-Nathan H., Buvat J. et al. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: A randomized double-blind placebo-controlled trial. J. Sex. Med. 2004;1:168-178.
- Nieschlag E., Swerdloff R., Behre H.M. et al. Investigation, treatment andmonitoring of late-onset hy-pogonadism in males: ISA, ISSAM and EAU recommendations. Int.J. Androl. 2005;28:125-127.
- NIH Consensus Development Panel of Impotence. Impotence. JAMA. 1993;270:83-90.
- Padma-Nathan H., McMurray J. G., Pullmann W.E. et al. On-demand IC351 enhances erectile function in patients with erectile dysfunction. Int. J. Import. Res. 2001;13:2-9.
- Porst H., Padma-Nathan H. The efficacy and tolerability of vardenafil, a neworal selective phosphodiesterase type 5 inhibitor in patients with erectiledysfunction: The first at-home clinical trial. Int. J. Import. Res. 2001;13:192-199.
- Rosen R., Cappelleri J., Smith V. et al. Development and evaluation of anabridged,5-item version of the In-ternational Index of Erectile Function (IIEF5) as a diagnostic tool for erectile dysfunction. Int. J. Import. Res. 1999;11:319-326.
- Rosen R. C., Riley A. Wagner G. et al. The International Index of Erectile Function (IIEF): a multidimen-sional scale for assessment of erectile dysfunction. Urology. 1997;49:822.
- Shabsigh R., Padma-Nathan H., Gittleman M. et al. Intracavernous alpostadilalfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunctionafter failing sildenafil (Viagra). Urology. 2000;55:477-480.
- http://uroweb.org/fileadmin/guidelines/Guidelines_2014_5_June_2014.pdf
Қосымша файлдар
